SENS PubMed Publication Search
Menthol-Modified Quercetin Liposomes with Brain-Targeting Function for the Treatment of Senescent Alzheimer's Disease
ACS Chem Neurosci. 2024 May 23. doi: 10.1021/acschemneuro.4c00109.
Wan-Ying Liu 1, Yang Yu 1, Juan Zang 1, Yang Liu 1, Feng-Rui Li 1, Lu Zhang 1, Rui-Bo Guo 1, Liang Kong 1, Ling-Yue Ma 2, Xue-Tao Li 1
Abstract:
...The blood-brain barrier (BBB) poses a significant challenge to the effective delivery of therapeutics for AD. Prior research has demonstrated that menthol (Men) can augment the permeability of the BBB. Consequently, in the current study, we modified Men on the surface of liposomes to construct menthol-modified quercetin liposomes (Men-Qu-Lips), designed to cross the BBB and enhance quercetin (Qu) concentration in the brain for improved therapeutic efficacy. The experimental findings indicate that Men-Qu-Lips exhibited good encapsulation efficiency and stability, successfully crossed the BBB, improved oxidative stress and neuroinflammation in the brains of aged mice, protected neurons, and enhanced their learning and memory abilities.
PMID: 38780450
Tags: Alzheimer’s, blood-brain barrier, brain, drug delivery, Menthol, mice, quercetin